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Abstract
Although the c-Myc (Myc) oncoprotein controls mitochondrial biogenesis and multiple enzymes involved in oxidative
phosphorylation (OXPHOS), the coordination of these events and the mechanistic underpinnings of their regulation remain
largely unexplored. We show here that re-expression of Myc in myc2/2 fibroblasts is accompanied by a gradual
accumulation of mitochondrial biomass and by increases in membrane polarization and mitochondrial fusion. A correction
of OXPHOS deficiency is also seen, although structural abnormalities in electron transport chain complexes (ETC) are not
entirely normalized. Conversely, the down-regulation of Myc leads to a gradual decrease in mitochondrial mass and a more
rapid loss of fusion and membrane potential. Increases in the levels of proteins specifically involved in mitochondrial fission
and fusion support the idea that Myc affects mitochondrial mass by influencing both of these processes, albeit favoring the
latter. The ETC defects that persist following Myc restoration may represent metabolic adaptations, as mitochondrial
function is re-directed away from producing ATP to providing a source of metabolic precursors demanded by the
transformed cell.
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Introduction
As one of the most frequently deregulated oncoproteins in
human cancer [1,2] c-Myc (hereafter, Myc) exerts pleiotropic
effects on proliferation, survival, cell cycle, size, differentiation,
genomic stability, and metabolism [3,4,5,6]. As might be
anticipated for a protein exerting such global influence, Myc
regulates a large number of downstream target genes transcribed
by RNA polymerases I–III [4,7,8,9,10,11]. A significant number
of Myc’s Pol II-regulated transcripts encode proteins involved in
ribosome biosynthesis, aerobic and anaerobic metabolism, and
mitochondrial biogenesis [12,13,14,15]. It is believed that the
proteins encoded by these genes are needed to sustain the high
proliferative demands of transformed cells [16].
The metabolic reprogramming that results from Myc deregu-
lation is exemplified by the ‘‘Warburg effect’’ whereby ATP
originating from mitochondrial sources is largely supplanted by
that derived from glycolysis, even in oxygen-rich environments
[16]. Among the benefits thought to be afforded by the switch to
this less efficient mode of energy generation is a redirecting of
TCA intermediates away from ATP production and towards the
synthesis of lipid, protein and nucleic acid precursors that serve the
increased synthetic demands of the rapidly proliferating trans-
formed cell [14,16,17,18]. The resultant increases in mitochon-
drial biogenesis and metabolism that accompany this reprogram-
ming are at least partly explained by the ability of Myc to regulate
the expression of TFAM, a major determinant of mitochondrial
DNA replication [12], as well as PGC-1a [19] and PGC-1b [15],
which regulate mitochondrial mass and energy metabolism [20].
In addition to increased mitochondrial number, the fusion of
pre-existing organelles could provide an independent means of
increasing functional efficiency in the face of Myc deregulation.
Normally, fusion is thought to allow the mixing and dilution of
oxidatively damaged membranes and intra-mitochondrial contents
whose excessive accumulation can otherwise lead to the compli-
cations such as: the uncoupling of oxidative phosphorylation
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(OXPHOS), the depletion of ATP pools, and the loss of inner
mitochondrial membrane permeability [13,21]. Fusion might thus
complement Myc-mediated de novo biosynthesis by minimizing the
number of irreversibly damaged mitochondria and thereby
prolonging their life spans [22,23,24,25]. This protective function
would be particularly valuable given the fact that mitochondria are
the major source of the reactive oxygen species (ROS) that are
elevated by Myc overexpression [26,27]. The larger and more
efficient mitochondria might also be better able to serve the
metabolic needs of the more actively proliferating transformed cell,
perhaps in a capacity analogous to that described in hypertrophic
cardiac muscle [19,28].
Fusion, however, is only partially effective at preserving
mitochondrial integrity. In the face of overwhelming damage,
mitochondria fission produces small, dysfunctional organelles that
can be selectively eliminated by the autophagosomal machinery
[29]. Fission is also used to reduce mitochondrial mass in the face
of rapid reductions in metabolic demands [30]. Thus, both
mitochondrial mass and function appear to be highly responsive to
the metabolic environment and are coordinately orchestrated by a
well-balanced combination of de novo synthesis and remodeling via
the fission/fusion processes [31,32].
In the current work, we have investigated the kinetics of
mitochondrial assembly and disassembly, along with the mecha-
nisms underlying these processes, by inducing or inactivating Myc
in several cell types. We find that conditional Myc depletion is
associated with a rapid decline in mitochondrial structural
integrity and function, as well as abnormalities in the electron
transport chain (ETC) supercomplexes. In contrast, Myc re-
expression leads to relatively slower and asymmetric normalization
of mitochondria mass and high rates of OXPHOS, despite only
partial reversal of ETC complex abnormalities. The coordination
of these structural and functional alterations seems to occur in
tandem with changes in the levels of several key proteins involved
in mitochondrial fission and fusion. These findings shed light on
the mechanisms underlying the increases in mitochondrial mass
and metabolic reprogramming that accompany Myc deregulation
in cancer.
Results
Control of mitochondrial structure by Myc
Initially, we employed three rat fibroblast lines: one with
endogenous levels of Myc (myc+/+) [33], an isogenic line bearing a
homozygous deletion of myc (myc2/2) [34], and myc2/2 cells
stably transduced with a lentiviral vector encoding wild-type
human Myc (myc2/2wtMyc cells). Immunoblotting showed that
Myc was overexpressed in myc2/2wtMyc cells relative to myc+/
+cells (Figure S1). Differential Myc expression resulted in
significant ultrastructural differences as observed by transmission
electron microscopy (Figure 1a). Of particular note was that the
mitochondria of myc2/2 cells were not only less abundant and
smaller (average length approx. 500 nm) than those of myc+/+ cells
(average length approx. 800 nm), but lacked their more elaborate
cristae patterns. Additionally, the mean mitochondrial length in
myc+/+wtMyc cells was over 50% greater than that of myc+/+ cells
(approx. 1300 nm, Figure 1b). From these studies, we conclude
that endogenous Myc plays a role in mitochondrial size and
structural integrity.
In order to study the Myc-induced changes in mitochondria as a
function of time, we next utilized myc2/2 cells transduced with a
retrovirally-encoded, 4-hydroxytamoxifen (4-HT)-responsive Myc-
estrogen receptor (MycER) fusion protein [35], which we hereafter
refer to as MycER cells. In the absence of 4-HT, the MycER
fusion protein is sequestered in the cytoplasm [35,36]. After
binding 4-HT, MycER undergoes a conformational change, is
shuttled to the nucleus, and becomes transcriptionally active.
We used 10-n-nonyl-acridinium-orange-chloride (NAO) to
quantify mitochondrial mass in MycER cells in the logarithmic
growth phase. Following the addition of 4-HT, an increase in
NAO staining was noted over the ensuing three to four weeks.
Upon reaching this stage of ‘‘chronic’’ exposure (i.e. .28 days), 4-
HT was removed from the medium and cells were again stained
with NAO, which revealed that the previously observed increase in
mitochondrial mass was reversible, with NAO staining patterns
gradually decreasing, but remaining at elevated levels for as long
as 10 days (Figure 2a).
The same cells were stained with MitoTrackerH Deep Red
which also measures mitochondrial mass, but does so in a manner
that is more dependent on the maintenance of mitochondrial
membrane potential ([25,37,38]; Figure 2a). We noted a somewhat
more gradual increase in this signal following the addition of 4-
HT, but a much more rapid decline upon its removal. A similar
pattern was seen in the corresponding epifluorescence images of
the cells (Figure 2b), suggesting that the maintenance of
mitochondrial membrane potential is more dependent on ongoing
Myc activity than is mitochondrial mass. In the absence of 4-HT,
MycER cells were similar in appearance to myc2/2 cells with
regard to mitochondrial morphology (Figure 2c). Upon activation
of Myc activity, the normalization of mitochondrial length and
cristae patterns appeared to occur somewhat more rapidly than
did the normalization of total mitochondrial mass. Similarly, these
properties were also lost more rapidly than mass upon removal of
4-HT.
Mitochondria are highly interconnected in a manner that often
correlates with their mass and function [39]. To determine
whether this was the case with the rat fibroblasts being studied
here, we generated space filling overlays over three-dimensional
reconstructions from serial confocal images obtained on Mito-
TrackerH-stained MycER cells exposed to 4-HT for differing
periods of time. Both untreated cells and those from which 4-HT
had been removed, showed the reduced mitochondrial mass and
loss of connectivity previously noted for myc2/2 cells. (Figures 2d
and Video S1). In contrast, chronic 4-HT treatment was
associated with a dense and highly interconnected mitochondrial
network. We also noted a tendency for the mitochondria of these
latter cells to be highly concentrated in a peri-nuclear pattern. The
removal of 4-HT was associated with a selective migration of
mitochondria away from nuclei and a more dispersed distribution.
From the above studies, we conclude that mitochondrial mass
responds gradually to Myc induction and withdrawal, whereas
changes in membrane potential and interconnectivity are more
rapid, particularly following 4-HT removal. Finally, a preferential
re-localization of mitochondria to sites immediately adjacent to
and/or connected with the nuclear membrane occurs following
Myc induction.
Control of mitochondrial function by Myc
The previous studies suggested that Myc-associated changes in
mitochondrial mass and structure might also be accompanied by
altered mitochondrial function, particularly in light of the rapid
decline in MitoTracker Deep Red staining (Figure 2a), which is
known to be partially dependent on membrane polarization [40].
To investigate this further, we first compared mitochondrial
membrane polarization in living myc2/2, myc+/+, and myc2/
2wtMyc cells using the JC-1 dye [41]. We measured the ratio of
red-shifted JC-1 aggregates, whose formation is favored under
conditions of high membrane potential, and green-shifted
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monomers, which tend to predominate under conditions of low
membrane potential [41]. As seen in Figure 3a, the structurally
abnormal mitochondria of myc2/2 cells showed a nearly ten-fold
reduction in membrane polarization relative to that of myc+/+ and
myc2/2wtMyc cells, with the latter showing no evidence of
hyperpolarization as has been reported to occur in activated T-
cells [42].
Having established that the enforced expression of Myc restored
mitochondrial membrane potential, we next asked whether basal
levels of oxidative phosphorylation (OXPHOS) were affected. We
have previously shown that another rat fibroblast line, Rat1a, is
more reliant on glycolysis than OXPHOS for its basal energy
requirements but that Myc over-expression significantly increases
the rates of both [43]. We used the XF24 Extracellular Flux
Analyzer to measure oxygen consumption rate (OCR), which
serves as a reliable surrogate for OXPHOS [44]. Our findings in
myc2/2, myc+/+ and myc2/2wtMyc cells were consistent with
our previous results. As seen in Figure 3b, basal OCR, as
measured between 0 and 19 min. was approximately two-fold
higher in myc+/+ cells than in myc2/2 cells and an additional 2–
2.5-fold higher in myc2/2wtMyc cells; thus, OCR was largely
correlated with the degree of Myc expression and/or de-
regulation.
The cell lines were then sequentially exposed to four metabolic
inhibitors to provide a profile of bio-energetic capacity. The first
inhibitor, oligomycin (Figure 3b, addition A at 19 minutes), blocks
the ATP synthase activity of Complex V and led to the expected
cessation of respiration in all cell lines. Cyanide p-trifluoro-
methoxy-phenylhydrazone (FCCP; Figure 3b addition B at
46 minutes) was next injected to promiscuously restore proton
flow. The increase in FCCP-mediated OCR provided a measure-
ment of the maximal respiratory rate of cells, which was
significantly higher in myc2/2wtMyc cells. The metabolic
response seen between the addition of FCCP and 2-deoxy-D-
glucose (2-DG), which inhibits glycolysis (addition C at 74 min-
utes), was representative of the so-called ‘‘spare respiration
capacity (sRC)’’ [45,46]. myc2/2 cells had the lowest sRC,
displaying approximately 30% lower levels than myc+/+ cells,
whereas sRC was 10.6-fold higher in myc2/2wtMyc cells.
Following the addition of 2-DG, myc2/2wtMyc cells displayed
a further increase in OCR that, in combination with the sRC,
represents the total reserve respiratory capacity [45,46], which was
20-fold higher than the level observed in myc2/2 cells. Finally,
the injection of rotenone (injection D at 102 minutes), which
inhibits Complex I, resulted in the complete cessation of electron
flow and oxygen consumption in all cell lines. Taken together,
these data show that Myc increases both actual baseline
OXPHOS as well as the potential to achieve higher levels, in
the face of otherwise normal mitochondrial mass.
We next investigated the relationship between OXPHOS and
ATP levels in the above cell lines. We found that myc+/+ cells and
myc2/2wtMyc cells each contained about three-fold higher
steady-state levels of ATP than myc2/2 cells (Figure 3c). The
inhibition of glycolysis by 2-DG was associated with a nearly
complete loss of net ATP levels whereas the inhibition of Complex
I by rotenone was associated with much more modest decreases.
Figure 1. Levels of Myc affect mitochondrial structure in rat fibroblasts. (a) Mitochondrial ultrastructure. The indicated cell lines were
examined by transmission electron microscopy. Representative mitochondria are presented. Note the smaller and cristae-deficient mitochondrion of
the myc2/2 cells (arrow) and the complete restoration of this defect in myc2/2wtMyc cells. (b) Mitochondrial length. Mean mitochondrial length in
each cell line was determined by measuring at least 30 individual mitochondria from images of multiple cells obtained by transmission electron
microscopy. The student t-test was used to calculate the p-values indicated in the figure.
doi:10.1371/journal.pone.0037699.g001
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These results suggested that, despite overall higher basal levels of
OXPHOS and respiratory reserve capacity of myc2/2wtMyc
cells, the majority of their ATP supply is derived from glycolysis.
This was confirmed by concomitant measurements of the
extracellular acidification rate (ECAR) (Figure S2). These results,
which measure the increased acidity of the medium as glucose is
converted to lactate, showed that ECAR also correlated with Myc
expression and were consistent with previous findings that
constitutive ectopic Myc expression in Rat1a fibroblasts is
associated with a high rate of glycolysis [43]. Relative to myc2/
2 cells, myc2/2wtMyc cells showed approximately three-fold
higher levels of ECAR (Figure S2). These results were largely
reproduced in MycER cells where net ATP content was observed
to increase as a function of time of Myc induction and where ATP
production was completely abrogated by 2-DG (Figure 3c).
The finding that myc+/+ cells and myc2/2wtMyc cells
contained equivalent ATP levels seemed at first to be inconsistent
with their different rates of glycolysis and OXPHOS. We therefore
measured ATP half-life in each cell line and showed it to be
shorter in myc2/2wtMyc cells (2.661.0 minutes) than in myc+/+
cells (3.660.8 minutes; Figure S3; p = 0.02). Taken together, these
results suggest that the apparent discrepancy between ATP levels
and rates of OXPHOS in myc+/+ and myc2/2wtMyc cells can
likely be explained by higher rates of ATP turnover by the latter
cells.
Finally, we asked whether the effects of deliberately enforced
Myc expression on mitochondrial structure and function could be
observed in cells in which high endogenous Myc levels were a
natural consequence of the transformed state. We therefore
repeated several of the above studies in human A549 non-small
cell lung cancer cells stably transduced with a lentiviral vector
Figure 2. Temporal changes in mitochondrial density and structure in response to Myc. (a) Mitochondrial Mass. MycER cells were exposed
to 4-HT for up to 35 d at which point 4-HT was removed. At the indicated times, cells were stained with NAO and MitoTracker Deep Red and analyzed
by flow cytometry. Values are expressed relative to control cells not exposed to 4-HT, which were arbitrarily set to a value of one. (b) Mitochondrial
mass by microscopy. MycER cells stained with MitoTracker Red were observed by epifluorescence microscopy at low power. The intensity of staining is
consistent with the finding from flow cytometry. (c) Mitochondrial ultrastructure. MycER cells were exposed to 4-HT for the indicated times and
observed by transmission electron microscopy. Representative mitochondria from each time point are depicted. Note that the untreated cells had
small, cristae-deficient mitochondrion similar to those of the myc2/2 cells. After several weeks of Myc induction the mitochondria took on a more
normal and mature appearance. The size of the mitochondria began to decrease as 4-HT was removed from the media. The addition of 4-HT to cells
lacking the MycER construct had no effect on any of the above-measured mitochondrial properties (not shown). (d) Mitochondrial shape. MycER cells
were observed under live confocal microscopy either prior to or following the addition of 4-HT for 35 days. 4-HT was then removed and the cells were
imaged again 1 day or 10 days later. Mitochondria were stained with MitoTracker Deep Red and 3-dimensional reconstructions of the cells were
performed from a series of z-stacks. Shown are representative images with a space-filling overlay to emphasize the mitochondria. Note the loss of
total mitochondria and the decrease in interconnectivity upon removal of 4-HT. Additional cells can be seen in a video detailing the three-
dimensional structure (Video S1).
doi:10.1371/journal.pone.0037699.g002
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containing a doxycycline (DOX)-inducible Myc-targeted shRNA
(A549-shMyc cells). This vector also expressed red fluorescent
protein, which permitted the convenient indirect monitoring of
shRNA induction. As seen in Figure 4a, a four day DOX
treatment of A549-shMyc cells led to the expression of red
fluorescent protein, the abrupt cessation of proliferation, and a
more flattened cellular morphology. Evaluation of these cells by
immunoblotting showed these features to be associated with a
nearly complete loss of endogenous Myc expression and a
subsequent two-fold reduction in MitoTrackerH Green staining
(Figure 4b and c). Metabolic analysis of these cells also revealed
baseline levels of OXPHOS of DOX-treated A549-shMyc cells to
be more than ten-fold reduced relative to non-DOX-treated cells
(Figure 4d). Similar to what had been observed in myc2/2 cells,
DOX-treated A549-shMyc cells displayed relatively low basal
OXPHOS with little sRC, whereas cells grown in the absence of
DOX showed higher levels of both basal OXPHOS and sRC.
Collectively, these data indicate that Myc has a positive effect on
mitochondrial mass and function in both rat and human cells.
Regulation of mitochondrial ETC complexes by Myc
The mitochondrial ETC consists of four major protein
complexes that mediate a series of redox reactions involving
electron transfer from donors (NADH, succinate and fatty acid
oxidation products directly through coenzyme Q) to electroneg-
ative acceptor molecules terminating with the reduction of oxygen
to water [47]. The energy generated during this step-wise process
is used to pump protons from the mitochondrial matrix to the
inter-membrane space, thereby establishing an electrochemical
proton gradient, which ultimately powers the conversion of ADP
to ATP via ATP synthase (Complex V). Due to the large
differences in the observed rates of OXPHOS and ATP
biosynthesis in myc+/+, myc2/2, and myc2/2wtMyc cells
(Figure 3), we compared the relative levels of their respective
ETC complexes using blue native gel electrophoresis (BNGE) and
scanning densitometry (Figure 5a and b). The identification of
each complex was further confirmed by silver staining of SDS-
PAGE gels to confirm the identity of individual subunits (not
shown) and by in situ gel activity stains (see below) [48].
Figure 3. Mitochondrial function. (a) Mitochondrial membrane potential. Cells were stained with JC-1 and analyzed by flow cytometry. The degree
of mitochondrial membrane depolarization was measured by a decrease in the red/green fluorescence ratio. Values are expressed relative to those of
myc+/+ cells, which were arbitrarily set to one. (b) OXPHOS. A Seahorse Bioscience XF24 Extracellular Flux Analyzer was used for the real-time
determination of the oxygen consumption rate (OCR). Each inhibitor was injected at the times indicated by the arrows (injections: A-oligomycin, B-
FCCP, C-2-DG, D-rotenone). A typical experiment, performed in triplicate wells is shown. The experiment was repeated on at least three occasions in
replicates of four with similar results. When compared to myc2/2 cells, the p values for the basal OCR for myc+/+ cells = 0.000004 and for myc2/
2wtMyc cells = 0.000001. (c) Steady-state ATP levels. The steady-state levels of ATP were measured for the myc+/+, myc2/2, and myc2/2wtMyc
fibroblasts (left) and in MycER cells (right). The assays were performed both in the absence and presence of inhibitors of glycolysis (2-DG) and
OXPHOS (rotenone) inhibitors.
doi:10.1371/journal.pone.0037699.g003
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Relative to myc+/+ cells, myc2/2 cells showed decreases of
several respiratory complexes, most notably Complex I, whose
levels were reduced approximately four-fold (Figure 5b). Less
pronounced reductions were also noted in Complexes II, III, and
monomeric Complex V (Vm). These results stand in contrast to
the minimal change in Complex IV between these two cell lines.
Mitochondria from myc2/2 cells also contained an unidentified
complex (‘‘Complex X’’; Figure 5a) that was increased more than
four-fold relative to the other two cell types. Preliminary analysis of
Complex X by mass spectroscopy indicates that it contains some of
the subunits from Complexes II–V, amongst other proteins.
Some ETC complexes are also found in higher order structures,
either as homodimers, or in association with other complexes. For
example, Complex V occurs in both monomeric (Vm) and dimeric
(Vd) forms, with the latter having been proposed to be more
enzymatically efficient [49]. Similarly, all individual complexes can
associate in various combinations to form more efficient super-
complexes (SCs), such as those comprised of Complexes I+III+IV
[50]. These higher order structures were also depleted in myc2/2
cells as evidenced by the approximately two-fold and five-fold
decreases in Complex Vd and SCs, respectively (Figures 5b and
5c).
Given the restoration of mitochondrial mass and OXPHOS in
myc2/2wtMyc cells, it was expected that they would have
similarly normal ETC complexes; rather, they showed only a
partial restoration of ETC complexes. Specifically, these cells
displayed levels of complexes I, II, Vm, Vd, and SCs that were
intermediate to those of myc2/2 and myc+/+ cells (Figure 5a and
b). Thus, the restoration of Myc by its enforced over-expression
only partially corrected the ETC complex abnormalities seen in
myc2/2 cells.
Next, we studied the enzymatic activities of Complexes I and V
using previously described in situ activity stains [48,51,52]. These
studies showed that Complex I activity in myc+/+ cells resided in
both the Complex I and SC bands and was decreased by nearly
two-thirds in myc2/2 cells (Figure 5c). Overall, total Complex I
activity was only partially restored in myc2/2wtMyc cells
(Figure 5c).
Figure 4. Mitochondrial structure and function in human A549 cells. (a) Effect of Myc shRNA induction. A549 cells expressing doxycycline
(DOX)-inducible Myc shRNA were exposed to DOX for 4 days after being grown to 50–75% confluency. The upper right panel shows the signal from
the co-expressed RFP. The upper left panel shows the same cells grown in the absence of DOX. The lower panels represent changes in growth as a
result of DOX exposure following the plating of equal numbers of cells and a subsequent four day period of growth +/24-HT. (b) Endogenous Myc
protein levels. Immunoblotting for Myc protein in control, non-DOX-treated cells or those exposed to DOX for four days. b-actin was used as a loading
control. (c) Mitochondrial mass. Cells were exposed to DOX for four days and stained with MitoTracker Green. (d) OXPHOS. A typical experiment as
performed on the Seahorse is shown for cells grown in the presence and absence of DOX for four days. Included are control A549 transduced with a
lentiviral vector expressing a scrambled shRNA sequence and which do not display any changes in OXPHOS when exposed to DOX.
doi:10.1371/journal.pone.0037699.g004
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Similar in situ measurements of Complex V ATP synthase
activity showed an even more profound reduction in myc2/2 cells
than indicated by the total protein levels depicted in Figure 5b. In
this assay, total Complex V activity averaged only 15% of that
measured in myc+/+ cells, with Vm and Vd activities being
reduced comparably (Figure 5d). As had been seen with Complex
I, the re-expression of Myc in myc2/2wtMyc cells only partially
restored Complex V activity, with virtually the entire correction
occurring at the level of Vm. Overall, these results clearly show
that Myc overexpression does not restore either normal respiratory
chain function or structure despite normalizations of mitochon-
drial size, mass and ATP content.
Regulation of mitochondrial fusion and fission proteins
by Myc
Mitochondria are dynamic and interconnected organelles
whose overall structural and functional integrity are maintained
by a balance between fusion and fission [24,25,32]. Because the
smaller and poorly communicating mitochondria of myc2/2 cells
could reflect alterations in either or both of these pathways, we
examined several key fusion and fission proteins. Those in the
former category included the inner membrane-embedded
GTPase, Opa1, which plays important roles in the maintenance
of mitochondrial shape and cristae formation [32] and the
mitofusins Mfn1 and Mfn2 [53], which interact with each other
as well as Opa1, and positively regulate membrane potential,
metabolism and survival [22,24,25,32,54,55,56]. Proteins in the
latter category included the dynamin-like protein Dlp1 and Fis1,
which are believed to trigger fission as a result of their interaction
on the outer mitochondrial surface [57,58].
Western analysis of the above cell lines showed both fusion and
fission proteins to be expressed at somewhat higher levels in myc+/
+ cells when compared to myc2/2 cells (Figure 6a). This ranged
from a minimal increase in levels of Mfn1 to larger increases in the
levels of Fis1 and Opa1. Although our findings were mostly similar
in myc2/2wtMyc cells, Opa1 and Dlp1 levels generally exceeded
those of myc+/+ cells. These results were largely confirmed in
MycER cells where long-term activation of MycER by 4-HT was
again associated with variable increases in most of the proteins,
with the largest and most significant increase observed for Mfn1,
whose level increased more than two-fold when compared to
untreated myc2/2wtMyc cells (Figure 6b). Surprisingly, there was
no decline in fission or fusion protein levels upon 4-HT removal,
despite the previously observed loss of mitochondrial mass
(Figure 2a).
Given the foregoing results, as well as our evidence indicating
that loss of Myc decreased the connections between mitochondria
(Figure 2d), we next quantified the amount of fusion activity in
MycER cells (Figure 7). Cells that were maintained in 4-HT for
over four weeks were stably transduced with lentiviral vectors
expressing GFP and DsRed proteins that were targeted to
Figure 5. Electron Transport Chain complexes. (a) Blue native gel electrophoresis. A representative blue native gel is depicted. (b) Quantitation of
complex formation. The histogram is representative of the optical density of Coomassie blue staining for at least three separate experiments. In
comparison to the myc+/+ cells, p values were generated and the strains with values ,0.05 are indicated with an asterisk. (c) Complex I in situ gel
activity. Enzymatic activity staining was performed for Complex I. Depicted is a representative experiment. Note that Complex I activity could be
detected in the previously identified Complex I band as well as the bands that represent higher order supercomplexes (SC). Total activity of Complex
I+SC was calculated for myc+/+ cells and arbitrarily set to 100%. (d) Complex V in situ gel activity. Enzymatic activity staining was performed for
Complex V. Shown is a representative experiment. Total activity of Complex V (represented as the sum of individual Vm and Vd activities) was
calculated for myc+/+ cells and arbitrarily set to 100%.
doi:10.1371/journal.pone.0037699.g005
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mitochondria by virtue of being fused to the mitochondrial
localization signal for subunit VIII of cytochrome c oxidase
(Figure 7a). These cells were then co-plated and either maintained
in 4-HT or had the inducing agent removed from the medium 24
or 48 hours prior to inducing plasma membrane fusion with
polyethylene glycol as previously described [25,59]. The degree of
fusion was measured by quantifying GFP and DsRed co-
localization in the resulting heterokaryons (Figure 7b). MycER
cells maintained in 4-HT displayed approximately 70% fusion of
mitochondria, within two hours of PEG fusion, whereas cells from
which 4HT had been removed showed a significantly reduced
degree of fusion (Figure 7c). Taken together, these data indicate
that mitochondrial biogenesis in response to Myc induction is
associated with a coordinated and complex alteration of both
fusion and fission proteins, which ultimately favors the former
activity. Moreover, and similar to the changes seen in mitochon-
drial mass and polarization (Figure 2a), this process is rapidly
responsive to changes in Myc levels.
Discussion
Previous studies have shown that Myc regulates mitochondrial
biogenesis and that many enzymes of the OXPHOS and glycolytic
pathways are under direct Myc control [12,15,19]. Precisely how
Myc coordinates these activities or other aspects of mitochondrial
structure and function remains poorly understood. We have shown
here that changes in mitochondrial structure and function are
temporally regulated in a highly controlled manner in response to
changes in Myc levels. These changes are not symmetrical but
instead occur more rapidly in response to Myc’s inactivation than
to its activation. Most notably, membrane potential and inter-
connectivity are lost much more rapidly than mitochondrial mass
upon Myc inactivation (Figure 2a). Although we do not
understand the basis for this temporal asymmetry, it is tempting
to speculate that Myc is primarily responsible for maintaining
mitochondrial membrane potential and may do so by increasing
membrane fusion. We are currently conducting studies to address
this phenomenon. Furthermore, the relatively slow response of
mitochondria biogenesis to Myc induction relative to other
features of the transformed state suggests that changes in
metabolism are not necessary for transformation per se, but rather
serve to provide for the more robust proliferative demands of
transformed cells [17,18,60]. These results are in keeping with our
recent finding that a point mutation in the transactivation domain
of Myc (Q131R) retains potent transforming and tumorigenic
competence despite being significantly impaired in its ability to up-
regulate both glycolysis and OXPHOS [43].
Among the more notable features of myc2/2 cells was the
relative paucity of mitochondria in the perinuclear region
(Figure 2d). This localization appears to be an on-going, active
process as mitochondria at these sites were preferentially lost in
MycER cells following 4-HT withdrawal. Close contact between
Figure 6. Western analysis of mitochondrial fusion and fission proteins. Western analysis was performed on whole cell lysates from (a)
myc+/+, myc2/2 and myc2/2wtMyc cells and from (b) Myc ER cells exposed to 4-HT for the indicated times. b-actin is used as a loading control
during each experiment. Densitometry was performed and the values were used to calculate a ratio of the protein expression relative to the level of
b-actin. This ratio was normalized and the value for myc2/2 for (a) and untreated MycER cells for (b) was set to 1. Experiments were repeated a
minimum of three times and the standard error between the experiments is shown.
doi:10.1371/journal.pone.0037699.g006
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mitochondria and the nuclear membrane has been proposed to
facilitate the transfer of ATP or metabolic precursors to sites of
particularly intense local utilization [61]. Similar perinuclear
clustering of mitochondria has previously been described in cells
that overexpress Mfn1 [62]. Such selective spatial organization is
also seen in striated muscle where mitochondria are in close
proximity to the sarcoplasmic reticulum and likely play a role in
Ca2+ buffering [63,64]. Whether the intimate and apparently fluid
association between mitochondria and nuclei described here also
has distinct functional consequences remains to be determined.
Regardless of the differences of these mitochondrial subsets, the
rapidity with which their spatial reorganization occurs in response
to abrupt changes in Myc levels shows a close correlation with the
structural and metabolic fluctuations that occur in parallel.
Overexpression of Myc in the myc2/2 background restored
mitochondrial mass and volume to wild-type levels, while
simultaneously giving rise to mitochondria that were longer than
those observed in myc+/+ cells (Figure 1). We speculate that these
longer mitochondria may be a direct result of increased fusion
activity. ETC complexes also remained quite abnormal in myc2/
2wtMyc cells (Figure 5); thus, the excessive OXPHOS potential of
myc2/2wtMyc cells (Figure 3b) cannot be explained by propor-
tionate changes in ETC complexes. These cells do possess a higher
glycolytic rate than the other cells (Figure S2), which is consistent
with our previous findings as well as with reports that Myc is a
major regulator of the Warburg effect [16,43,65]; therefore, much
of the energy requirement of these cells appears to be met by ATP
generated via aerobic glycolysis (Figure 3). That certain ETC
complexes and supercomplexes, and their activities, remained
abnormal in myc2/2wtMyc cells may therefore be one of the
factors leading to the up-regulation of glycolysis. This may also
underlie the well-known tendency of Myc over-expression to
induce high levels of reactive oxygen species [27] that might be
facilitated by structural and/or functional ETC abnormalities
leading to an increase leak of electrons, particularly at Complex I
[66]. Finally, the ETC abnormalities we have observed may
represent a metabolic adaptation that reflects a shift from the
production of ATP to the production of the lipid, protein and
nucleic acid intermediates needed to meet the higher proliferative
demands imposed as a result of Myc deregulation.
The mechanism underlying the changes reported here appears
to involve alterations in the levels and the activities of proteins that
coordinate mitochondrial fission and fusion. That both types of
proteins respond positively to Myc was unexpected and does not
allow for a simple model of how, collectively, they preside over
increases in mitochondrial mass, polarity and fusion. The degree
to which deviations in the normal ratios of these proteins in
response to Myc deregulation contribute to mitochondrial
structural and functional abnormalities is also a question for
future work.
In addition to regulating mitochondrial dynamics, fusion is
necessary to maintain structural and functional homogeneity, to
preserve mitochondrial genome integrity, and to ensure the proper
balance between energy generation and cellular mass
Figure 7. PEG Fusion Assay. (a) MycER cells exposed to 4-HT chronically were stably transduced with lentiviruses encoding mitochondrially
targeted DsRed or GFP. Photos show representative cells with mitochondrially-targeted fluorescent proteins. (b). Cells were co-plated in the presence
or absence of 4-HT and were treated with PEG following incubation with CHX. Cells were fixed stained with DAPI and heterokaryons were identified
and imaged by confocal fluorescent microscopy. (c) The degree of mitochondrial fusion was calculated by determining the percentage of co-localized
fluorescent signals with the use of the CoLocalizer Pro software package. Cells from which 4-HT was removed from the media for one or two days
were compared to cells constantly maintained in 4-HT.
doi:10.1371/journal.pone.0037699.g007
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[22,24,25,32,56]. Higher levels of fission proteins might be needed
to maintain homeostasis of the greatly increased mitochondrial
mass in Myc overexpressing cells as well as to provide a means for
the more rapid elimination of oxidatively damaged organelles that
are generated as a result of high levels of reactive oxygen species
induced by Myc [26,27]. Our results suggest that the increased
mitochondrial mass in response to Myc induction may be
associated with high levels of organelle turnover, thus necessitating
higher levels of both fission and fusion proteins.
In conclusion, we propose that Myc, which is among the first
genes activated in response to a broad array of growth factors,
serves to link the proliferative signals mediated by these factors
with mitochondrial biogenesis and function via the control of
fission and fusion processes [32]. That Myc appears capable of
independently controlling both of these arms, coupled with its
rapid induction by growth factors and its extremely short half-life,
provides the means by which mitochondrial supply and cellular
energy generation can be fine tuned to meet cellular proliferative
demands.
Materials and Methods
Cell culture and virus infections
The generation of myc+/+ and myc2/2 rat fibroblasts has been
previously described [33,34]. myc2/2wtMyc cells were generated
by stable transduction with a lentiviral vector expressing a full-
length human wtMyc as previously described [43], and cells were
selected for blasticidin resistance. MycER cells were also derived
from myc2/2 cells by transduction with the pBabePuro-MycER
retroviral vector and selection in puromycin [35]. To activate
MycER, 4-HT (Sigma-Aldrich, St. Louis, MO) was added to a
final concentration of 250 nM and the media was replaced every
48–72 hours for all experiments.
DsRed and GFP, both fused to the mitochondrial localization
signal of subunit VIII of cytochrome c oxidase (pMito-DsRed and
pMito-GFP, Clontech, Mountain View CA) were amplified using
the polymerase chain reaction and directionally subcloned into the
pLenti6/V5 lentiviral vector as recommended by the supplier
(Invitrogen, Carlsbad, CA). They were packaged into infectious
viral particles in 293FT cells and transduced into recipient cells
followed by selection in blasticidin. A549-shRNA cells were
derived from the A549 non-small cell lung cancer cell line by
transduction with a pTRIPZ lentiviral vector (Open Biosystems,
Huntsville, AL) encoding a DOX-regulatable bi-cistronic tran-
script for RFP and a shRNA directed against human Myc. Control
cells were transduced with the same vector encoding a scrambled
shRNA. Stably transfected cells were selected in puromycin and
those expressing the highest levels of RFP following overnight
exposure to DOX (1 mg/ml) were further selected by fluorescence-
activated cell sorting. The cells were then expanded in DOX-free
medium. All cell lines were propagated in Dulbecco’s-modified
minimal essential medium (D-MEM) containing 10% fetal bovine
serum, glutamine, and penicillin plus streptomycin as previously
described [67,68]. The working concentration of DOX was 5 mg/
ml and the media was replaced every 48 hr. All retroviral and
lentiviral work was approved by the University of Pittsburgh
Institutional Biosafety Committee and was performed under
BSL2+ conditions.
Fluorescence microscopy
Low power (206) fluorescent images were obtained using a
Zeiss Axiovert fluorescent microscope by direct observation of cells
grown on tissue culture dishes and maintained at 37uC and 5%
CO2. High power (606) images of cells grown to 50% confluency
on glass bottom 6-well tissue culture plates were obtained on a
Zeiss LSM710 confocal microscope at 0.5 mm intervals. Observa-
tion of mitochondria was possible following staining with
MitoTrackerH Deep Red FM as described below. The confocal
stacks of the mitochondria were uploaded into Imaris (Bitplane
Scientific Software) and a 3D reconstruction of the cells was
obtained. A surface was then placed over the MitoTracker positive
stain using the Imaris software. 3D movies of the reconstructed
mitochondria were then generated.
Electron microscopy
Cells were grown to confluency in 12-well tissue culture dishes
and fixed with 2.5% glutaraldehyde. Samples were prepared as
previously described [69] and subsequently were photographed
using a JEM 1,210 transmission electron microscope (JEOL,
Peabody, MA) equipped with a CCD camera (Advanced
Microscopy Techniques Corp., Danvers, MA) at 80 kV.
Quantitation of mitochondrial mass and membrane
potential
Mitochondrial mass was measured by staining live cells with
NAO and MitoTrackerH Green (Invitrogen, Carlsbad, CA). Cells
were grown to 50–75% confluency in a 6-well dish. The dyes were
diluted in RPMI media (final concentrations: MitoTrackerH
Green= 0.5 mM, NAO=20 nM) and exposed to the cells for
30 minutes at 37uC. Cells were washed with PBS, collected by
scraping and analyzed using a FACStar flow cytometer (Becton-
Dickinson Biosciences, San Jose, CA).
To measure mitochondrial membrane polarization, 16106 cells
were suspended in 1 ml PBS and incubated with JC-1 dye
(Invitrogen) at 0.2 mM for 30 minutes. Cells were pelleted by
centrifugation and re-suspended in 500 mL PBS. The cells were
analyzed by flow cytometry measuring both green and red
fluorescence. Relative degrees of mitochondrial polarization were
quantified by measuring the ratio of red-shifted JC-1 aggregates,
which are favored under conditions of high membrane potential,
and green-shifted monomers, which tend to predominate under
conditions of low membrane potential [41]. Additionally, cells
stained with MitoTrackerH Deep Red FM (final concentration
0.5 mM) were used to assess both mass and membrane potential.
PEG-Fusion Assay
56105 MycER cells expressing mito-GFP were co-plated with
the same number of MycER cells expressing mito-DsRed onto
glass coverslips in 12 well plates. The following day, the coverslips
were incubated with DMEM+cycloheximide (CHX, 33 mg/ml,
Sigma) for 30 min to inhibit de novo synthesis of fluorescent
proteins. Next, coverslips were incubated in 0.5 ml PEG 1500
(Sigma) for 1 min at room temperature, washed with
DMEM+CHX three times, and subsequently incubated in the
same medium at 37uC and 5% CO2. One or two hours later,
coverslips were fixed for 30 min with ice-cold 3.7% formaldehyde
in PBS, stained with DAPI and mounted onto glass microscope
slides. A minimum of 20 heterokaryons were observed using
confocal fluorescence microscopy from which the percentage of
co-localized fluorescence was calculated using CoLocalizer Pro
software (CoLocaliztion Research Software; [70,71]) and ex-
pressed as the percentage of mitochondrial fusion.
Measurements of cellular OXPHOS and glycolysis
All measurements were performed with a Seahorse Bioscience
XF24 Extracellular Flux Analyzer (Billirica, MA). Cells were
plated at 20,000 cells/well onto Seahorse 24 well plates 12–
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18 hours prior to the assay. Immediately following the addition of
fresh medium, O2 consumption rate (OCR) and proton produc-
tion, expressed as the extracellular acidification rate (ECAR), were
quantified to obtain baseline levels of these processes. The next
measurement was performed following the blockade of complex V
by 1 mM oligomycin (injection A). This causes a build-up of
protons across the inner mitochondrial matrix with subsequent loss
of electron flow. The addition of FCCP (final concentration
300 nM; injection B) causes the protons on the outside of the inner
membrane to be carried across to the mitochondrial matrix. The
addition of 2-deoxyglucose (2-DG) (final concentration 100 mM;
injection C) inhibits glucose uptake, glycolysis, and the generation
of acetyl coenzyme A from pyruvate for utilization as an initial
substrate for the TCA cycle. Finally, the injection of rotenone
(final concentration 1 mM; injection D) inhibits complex I, leading
to cessation of both electron flow and oxygen consumption.
Experiments were performed by simultaneously measuring three
to five replicates of each cell line. Relative effects were expressed as
areas under the curve measurements that were generated by the
manufacturer’s software.
Measurement of ATP levels
ATP levels were measured using the ATPliteTM Luminescence
Assay System (Perkin Elmer, Waltham, MA) according to
manufacturer’s instructions. 20,000–30,000 cells were grown
overnight in 96-well plates and were exposed to 100 ml of medium
with and without metabolic inhibitors at 37uC for the final
45 minutes prior to the assay. The concentrations of the inhibitors
were the same as those used for the Seahorse assay described above.
The half-life of ATP was determined by first growing the cells as
described above. Warm medium containing both oligomycin and
2-DG was then added and the cells were incubated at room
temperature. At various points thereafter, lysis solution was added
to stop the reaction. Luminescence was measured as described
above and the exponential line equation was used to calculate the
half-life.
Preparation of mitochondria from fibroblasts
Approximately 107 freshly harvested fibroblasts were re-
suspended in 0.5 ml of ice cold buffer 25 mM Tris-HCl,
pH 7.5; 100 mM KCl; 0.4 M sucrose containing protease
inhibitor cocktail (Sigma-Aldrich) and disrupted in a cell
homogenizer (Isobiotec, Heidelberg, Germany) for 10 strokes on
ice. The resultant homogenate was clarified by centrifugation at
5006 g for 10 min at 4uC, and the pellet was discarded. The
mitochondria-rich supernatant was then centrifuged at 14,0006 g
for 15 min. The pellet was washed twice with buffer A and re-
suspended in same buffer at a final protein concentration of 5 mg/
ml. Samples were either analyzed immediately or stored at
280uC.
Blue native gel electrophoresis (BNGE)
Eight mg of digitonin (MP Biomedicals, Solon, OH) was dissolved
in 200 ml of 30 mM HEPES buffer, pH 7.4, 150 mM potassium
acetate and 10% glycerol, heated at 95uC, then cooled on ice. One
mg of mitochondria, isolated as described above, was lysed by the
addition of digitonin to a final ratio of 1:8 protein:digitonin.
Following incubation on ice for 20 min, a Coomassie blue solution
(5% Coomassie blue G250 in 750 mM 6-aminocaproic acid) was
added (1/20 v/v), and the mixture was centrifuged at 14,0006g for
20 min at 4uC. The supernatant was then directly loaded onto a 3–
12%Native PAGENovex Bis-Tris gel (Invitrogen), and subjected to
electrophoresis at 80 V for 4 hours at 4uC in the buffer provided by
the supplier. Following electrophoresis, gels were stained with Bio-
Safe Coomassie G250 (Bio-Rad, Hercules, CA) for 30 min and
exhaustively de-stained with water. Stained gels were scanned and
the images analyzed for relative band density using AlphaEaseFC
2200 scanner and AlphaEaseFC software.
For confirmation of native complex identities, individual bands
were excised from the above gels, incubated in Laemmli SDS-
sample buffer (Bio Rad) for 30 min at room temperature and
electrophoresed on a Criterion pre-cast gel (Bio Rad) and
electrophoresed at 80 V for 2 hours followed by silver staining
(Sigma-Aldrich).
Complex I and V gel in situ activity stain
For Complex I activity measurements, the blue native gel was
placed in 3–4 ml of 2 mM Tris-HCl, pH 7.4 buffer containing
2.5 mg/ml nitrotertrazolinum blue chloride and freshly added
0.1 mg/ml NADH. The gel was incubated at 37uC for 1–2 hours
and then subjected to densitometric analysis. An average value
from 3 gels was calculated. To quantify the ATPase activity of
Complex V, gels were incubated in 3–4 ml of 34 mM Tris-glycine,
pH 7.8, 14 mM MgSO4, 0.2% Pb(NO3)2 with freshly added
8 mM ATP for 3 hours at 37uC. Bands were quantified as for
Complex I.
Immunoblotting
Cells were grown to approximately 90% confluency under
standard conditions and then harvested by trypsinization. After
washing twice in PBS, cell pellets were lysed in SDS-PAGE lysis
buffer without b-mercaptoethanol, and protein concentrations
were quantified using a BCA protein determination kit (Pierce,
Rockford, IL). 5 mg of total protein lysate from each cell line was
then resolved on a 10% SDS-polyacrylamide gel and transferred
to a PVDF membrane (Millipore, Inc., Bedford, NY) by
electrophoretic transfer according to manufacturer’s instructions
(Bio-Rad). Immunoblotting was performed as previously described
[72]. The antibodies and the concentration at which they were
used are listed in Table S1. The blots were developed using
chemiluminesence (Thermo Fisher Scientific, Rockford, IL).
Supporting Information
Figure S1 Western analysis for Myc expression. 5 mg of
whole cell lysates from myc+/+, myc2/2 and myc2/2wtMyc cells
were used to perform Western analysis with the 9e10 anti-Myc
antibody. b-actin is used as a loading control.
(TIF)
Figure S2 ECAR in rat fibroblasts. Extracellular acidifica-
tion rates (ECARs) were calculated concurrently with OCR.
ECAR is a surrogate measure of glycolysis and is expressed as a
function of time. Inhibitors were injected at the times indicated by
the arrows (injections: A-oligomycin, B-FCCP, C-2-DG, D-
rotenone). A typical experiment, performed in triplicate wells is
shown. The experiment was repeated on at least three occasions in
replicates of four with similar results.
(TIF)
Figure S3 ATP half life. ATP levels were measured for the
myc+/+ and myc2/2+wtMyc fibroblasts. The cells were incubated
for the indicated times in the presence of 2-DG and oligomycin. A
logarithmic curve was fit for each data set and the equation of the
line was used to calculate the half life. Depicted is a representative
experiment.
(TIF)
Table S1 Antibodies used in this study.
(PDF)
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Video S1 Mitochondrial structure changes following
Myc deactivation in MycER cells. MycER cells were
observed under live confocal microscopy either prior to (left) or
24 h after the removal of 4-HT. Mitochondria were stained with
MitoTracker Deep Red and 3-dimensional reconstructions of the
cells were performed from a series of z-stacks. Note the loss of total
mitochondria and the decrease in interconnectivity upon removal
of 4-HT. Furthermore, note the preferential loss of perinuclear
mitochondria.
(MOV)
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